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Abstract 
Renal dysfunction in the setting of heart failure is a common medical problem. 
This dysfunction can range from reversible ischemic changes to renal failure 
requiring renal replacement therapy. Patients who are candidates for 
mechanical circulatory support with left ventricular assistant device (LVAD) 
pose unique challenge with respect to receiving dialysis. We present a 47 year 
old patient who required renal replacement therapy peri-implantation of LVAD 
for management of acute on chronic kidney disease, and was discharged for 
chronic hemodialysis in an outpatient setting. In this report we highlight the 
challenges of managing volume overload in patients with impaired renal 
function refractory to optimal medical therapy as well as the possibility of 
implanting LVADs in patients on hemodialysis. 
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Background 
A significant number of patients with advanced heart failure have associated 
renal dysfunction before LVAD implantation. Medical management of those 
patients is often challenging as trying to treat one organ may lead to worsening 
of the other. The burden is exacerbated by the occasional need for renal 
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replacement therapy in the form of hemodialysis. Published studies on renal 
replacement therapy in the peri-implantation period of LVAD are limited by low 
number of nephrologists/dialysis teams who are experts in LVAD management 
during dialysis, and absence of specific details of renal replacement therapy 
utilized. For patients, who are not transplant candidates at the time of LVAD 
implant, but can potentially become heart or heart /kidney transplant candidates 
after a period of LVAD support, concomitant renal failure is of particular 
importance, and availability of chronic hemodialysis while on LVAD support may 
literally mean the difference between life and death.  
We present a patient with advanced heart failure who suffered from acute 
deterioration of his chronic kidney disease requiring renal replacement therapy in 
the peri-implantation of LVAD, and was eventually discharged for chronic 
outpatient hemodialysis after LVAD. 
Case Report  
A 47-year-old male with morbid obesity (weight 150 kg, body mass index 41.3), 
type 2 diabetes mellitus, hypertension, non-ischemic cardiomyopathy, and 
chronic kidney disease presented with shortness of breath and increased pedal 
edema bilaterally. Vital signs were within normal limits (HR 79 BPM and a BP 
101/67). Physical examination revealed an obese male in distress. Cardiac 
auscultation disclosed mild tachycardia and a regular rhythm without murmurs, 
gallops, or rubs. Lung auscultation disclosed crackles bilaterally. Basic metabolic 
profile was significant for mild hyponatremia (132 mg/dL) as well as elevations in 
creatinine (3.95mg/dL [baseline: 1.98mg/dL]) and blood urea nitrogen (BUN: 72 
mg/dL [baseline: 50 mg/dL]). NT-pro B-type Natriuretic Peptide (NT -proBNP) 
was 5540. Based on the clinical exam, he was diagnosed with acutely 
decompensated heart failure, and was initiated on intravenous diuretic therapy 
for preload reduction.  Right heart catheterization was also performed (right 
atrium 27 mmHg, pulmonary artery systolic/diastolic/mean   86/38/52 mmHg, 
pulmonary capillary wedge pressure 51 mmHg, Cardiac index was 1.96), 
demonstrating low cardiac output, and thus inotropic therapy was also started. 
His right heart catheterization was complicated by respiratory arrest due to 
hypoventilation in the setting of sedation, had to be intubated and put on 
mechanical respiratory support. Despite optimal medical therapy, his renal 
function continued to decline (creatinine and BUN of 6.09 mg/dL and 109 mg/dL 
respectively) and he was unable to be weaned off Milrinone. Patient was 
evaluated by nephrology team, who determined that his renal deterioration was 
functional, and did not represent an intrinsic renal disease. He was started on 
hemodialysis, and one month thereafter, was declared to have end stage renal 
disease. Initially, there was some hesitancy on the part of the cardiac transplant 
team to offer LVAD transplantation due to logistics involved in dialysis patients; 
however, the patient’s family had found a local dialysis center willing to accept 
the patient on mechanical support therapy. Eventually, after 2 months in the 
hospital, he underwent Heart Mate II LVAD implantation without any 
complications. Low dose intravenous Heparin and Warfarin were both started on 
postoperative day 1, and 28 days thereafter, was discharged home on warfarin 
with an international normalized ratio (INR) of 2, and a target range between 2 
and 3. Postoperatively, he continued to require renal replacement therapy. On 
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the day of discharge, his creatinine (Cr) and blood urea nitrogen (BUN) were 
5.07 mg/dL and 40 mg/dL, respectively. Since discharge, his outpatient 
hemodialysis has been uneventful, without significant changes in LVAD pump 
flow and pulsatile index. Has not had any bleeding or hemolysis complications 
related to anticoagulation and dialysis respectively. On his three month follow up, 
he reported feeling well, stating his insulin requirements has substantially 
decreased. He is active and has been walking several blocks without having any 
difficulties, which is a dramatic change from his pre-LVAD lifestyle. He has 
intentionally lost over 40 Lbs of weight and is making progress towards becoming 
a heart/kidney transplant candidate.  
Discussion   
LVAD is a well-established therapy that is employed either as a bridge to 
transplant or as a destination therapy for patients with heart failure refractory to 
conventional medical therapy. Recent data have shown that LVADs are 
associated with improved survival and better functional status for an extended 
period of time.  Criteria for candidate selection for long term LVAD therapy are 
not as strict as for heart transplantation, and more comorbid conditions are 
allowed (2). Specifically, renal insufficiency, which is secondary to heart failure, 
known as cardio-renal syndrome, should not preclude patients from mechanical 
circulatory support, especially since kidney function may improve after LVAD. 
Several studies have demonstrated dramatic improvements in renal function after 
LVAD implantation in patients with baseline creatinine values of 3.1–4.1 mg/dL 
and even in those dependent on short term renal replacement therapy before 
LVAD implantation (3-7). 
End stage renal disease with the need for chronic hemodialysis is a separate 
issue. Currently, it is considered a contraindication for LVAD implantation (1). 
Nevertheless, there are few dialysis centers that accept a patient with an LVAD. 
Typically, patients on LVAD and chronic hemodialysis are not dialysis dependent 
pre-implant, and become dependent on renal replacement therapy as a result of 
acute kidney injury in the postoperative period. They require prolonged 
ventilatory support and suffer from right ventricular failure post-LVAD (8).  
Access is yet another challenge for patients with LVAD who requires dialysis. 
First, fistula maturation is delayed or does not occur at all because of non-
pulsatile or marginally pulsatile blood flow (9). Second, these patients are at 
higher than normal risk of infection because of the driveline. LVAD driveline exit-
site infection and subsequent bacteremia that can spread to LVAD itself, is one 
of the most common causes of morbidity and mortality in these patients (10). 
Patel and colleagues recommend that if hemodialysis is pursued, long-term 
dialysis catheters should be avoided due to their high risk for infections (11). 
Some authors advocate peritoneal dialysis in order to minimize the risk of 
infection (12). 
In summary, patients with cardiac induced renal failure requiring renal 
replacement therapy in the pre-implantation period can still be considered for 
LVAD, especially as a bridge to transplantation. There are challenging and 
unique issues that arises in the course of delivering renal replacement therapy to 
an LVAD patient in either inpatient or outpatient setting. Appropriate selection of 
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candidates for implantation is critical for ensuring the best outcomes. If a patient 
is considered a candidate for implantation, a multidisciplinary team, including the 
cardiothoracic surgeon, heart failure physician, and LVAD nurses should involve 
themselves closely in educating dialysis unit team, nephrologists, patient, and 
family members about LVAD management during renal replacement therapy. 
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